Live Fireside Chat with Erik Compton
Ask the Experts: Cancer Risks as a Transplant Recipient
CareDx 6/7 ATC Symposium: Advancing Care in Kidney Transplantation – Groundbreaking Findings from ADMIRAL…
CareDx 6/6 ATC Symposium: AlloSure- dd-cfDNA Utility Beyond Kidney Transplantation
How COVID-19 is Changing Lung Transplant
COVID-19 Vaccines and the Latest Data on Immune Response in Transplant Patients
HeartCare: The Utility of Multi-Modality in Transplant Patient Care
AlloSure Lung: Donor-Derived Cell Free DNA as an Innovative Biomarker for Lung Transplant Patients
Decreasing Transplant Wait Times by Increasing Living Donation
EFI 2021 Virtual Session – Hybrid Capture Technology – Improvements with AlloSeq Tx17
EFI 2021 Virtual Session – CareDx Poster Review
EFI 2021 Virtual Session: AlloSeq HCT – The Latest Innovation in NGS-based Chimerism Testing
EFI 2021 Virtual Symposium – Revolutionizing Post-Transplant Monitoring: Better Outcomes start with…
EFI 2021 A streamlined AlloSeq Tx hybrid capture workflow: DNA to sequencing in a single day.
EFI 2021 Optimization of mixed pools of buccal and peripheral blood DNA for routine testing with AlloSeq Tx…
EFI 2021 Genetic risk factors in solid organ transplantation: beyond classical human leukocyte antigen
EFI 2021 Intra-Laboratory Evaluation of a Next-Generation Sequencing-Based Solution for Chimerism Monitoring
EFI 2021 Laboratory Validation of CE-marked AlloSeq cfDNA to Measure Donor-derived Cell-free DNA in…
EFI 2021 AlloSeq Tx Genotyping Using DNA Extracted from Saliva.
EFI 2021 Accurate, Reproducible and Sensitive Chimerism Monitoring with NGS-based AlloSeq HCT
Cancer as a Transplant Recipient: Understand Your Risks and Learn What to Do
Managing Medications with AlloCare
Life After Transplant: How to Navigate Your New Routine & Take Care of Your New Kidney
COVID-19 & Vaccines for Transplant Recipients